Top 50 Life Science Angel Investors in United States in January 2026
A list of 50 angel investors that invest in Life science startups based in United states. We rank investors based on the number of investments they made in Life science companies from United states. We update this investor list every month.Top 50 Life Science Angel Investors in United States in January 2026
| Investor | Life Science United States investments |
|---|---|
| Sahin Boydas | 5 |
| bumpkins profile | 4 |
| Milad Alucozai | 4 |
| Erik Peterson | 3 |
| Darian Shirazi | 3 |
| Kevin Moore | 3 |
| Esther Dyson | 3 |
| Chris Gibson | 3 |
| James Hong | 2 |
| Sridhar Iyengar | 2 |
| Elad Gil | 2 |
| Patrick Yang | 2 |
| Nitesh Banta | 2 |
| Zach Weinberg | 2 |
| Jeff Dean | 2 |
| Nat Turner | 2 |
| Kathryn Haun | 2 |
| CJ Reim | 2 |
| Joe Betts-Lacroix | 2 |
| Jonathan Milner | 2 |
| Jay Zaveri | 2 |
| Mei Z. | 2 |
| Michael Chambers | 2 |
| Peter Harris | 2 |
| Joshua Elkington | 2 |
| Kevin Mahaffey | 2 |
| Ankit Jain | 2 |
| Balaji Srinivasan | 2 |
| David R. Walt | 2 |
| Craig Mundie | 2 |
| Lars Fjeldsoe-Nielsen | 2 |
| Patrick Collison | 2 |
| Avichal Garg | 2 |
| Sujay Jaswa | 2 |
| Alec Nielsen | 2 |
| Brian S. Cohen | 2 |
| Aaron Levie | 1 |
| Ethan Oren Perlstein | 1 |
| Alice Zhang | 1 |
| Daniel M. Bradbury | 1 |
| Paul Manning | 1 |
| Matt Vining | 1 |
| Willard Umphrey | 1 |
| Norman Sorensen | 1 |
| Leonardo DiCaprio | 1 |
| Scott Garber | 1 |
| Noel Hall | 1 |
| Haig Farris | 1 |
| Dylan Taylor | 1 |
| Don Mattrick | 1 |
Sahin Boydas is a serial entrepreneur who co-founded startups in Silicon Valley.Sahin has built and managed remote teams for over a decade. He founded RemoteTeam.com, which was a payments and HR platform for remote teams, and was acquired by Gusto.He co-founded the movie marketing platform MovieLaLa, and was downloaded by millions with networkpartnerships. Movielala sold it to Gfycat. He co-founded a sticker platform called MojiLaLa and a consumer-facing Augmented Reality app, Leo AR.
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Series A, Series B
- United States, Mexico, Norway
Portfolio highlights
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
- Boost Robotics — Boost Robotics combines digital infrastructure with physical agents to revolutionize robotics solutions.
- Reach — Reach delivers long-range, wireless power-at-a-distance for defense, industrial, and critical infrastructure use cases. Eliminate manual charging and enable persistent operations with scalable wireless energy solutions.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
- Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Erik Peterson is the Founder at DormTrader.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Equity Crowdfunding, Series A
- United States, Canada, Algeria
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Darian Shirazi is the Managing Partner of Gradient.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, Germany, Canada
Portfolio highlights
- Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
- Twenty (YC S23) — Building a better Salesforce, powered by the Open Source community.
- Twenty — Twenty builds the modern salesforce, powered by the open source community.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Pre-Seed, Angel
- United States, India, Canada
Portfolio highlights
- Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
- Augmend — Create documentation and an AI assistant from any video.
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
- Health Care, Software, Medical
- Seed, Series A, Funding Round
- United States, Canada, Russian Federation
Portfolio highlights
- Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Seed
- United States, France, Switzerland
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
James Hong
Show more
Investment focus
- E-Commerce, Software, Internet
- Seed, Series A, Angel
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
A serial entrepreneur in connected medical devices and wearables, Sridhar is focused on strategy and management at Elemental Machines. Previously, Sridhar was a founder and director of Misfit, makers of elegant wearable products, which was acquired by Fossil in 2015. Prior to Misfit, he founded AgaMatrix, a blood glucose monitoring company thatmade the world’s first medical device connecting directly to the iPhone. AgaMatrix shipped 15+ FDA-cleared medical products, 2B+ biosensors, 6M+ glucose meters, with partnerships with Apple, Sanofi, and Walgreens. Sridhar holds over 30 US and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar. Beyond Elemental Machines, Sridhar has been known to run 13.1 miles on occasion and has sometimes been spotted on stage behind a wall of drums.
Show more
Investment focus
- B2B, Life Science, Information Technology
- Seed, Angel, Series A
- United States
Portfolio highlights
- Stedi — Stedi is the only programmable healthcare clearinghouse. We offer modern, AI-ready APIs for eligibility checks, claims, transaction enrollment, and more.
- Fuel — Rumtar88slot pilihan tepat pecinta slot, bonus member, cashback, turnamen, dan keamanan berlapis untuk bermain nyaman.
- Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, United Kingdom, Israel
Portfolio highlights
- Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
- Harvey — Harvey is an artificial intelligence technology service provider.
- Cognition — Cognition is an applied artificial intelligence lab that focuses on reasoning and code.
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Series A, Seed, Series B
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Nitesh Banta is the Co-Founder & CEO at B12.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, Canada, India
Portfolio highlights
- Vybe — Virtual Try-On & AI Styling for Fashion Stores
- Protege — Protege is the platform for AI Training Data. Protege works with data holders and model builders to empower them to share training data for AI model development.
- Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more
Investment focus
- Health Care, Software, Medical
- Seed, Series A, Pre-Seed
- United States, Israel, Colombia
Portfolio highlights
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
- Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
- Nym — Nym Health leverages advanced AI for medical coding, revolutionizing accuracy and speed within revenue cycle management. Discover the difference.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more
Investment focus
- Artificial Intelligence, Information Technology, Software
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Japan
Portfolio highlights
- Sophont — Multimodal foundation models for healthcare
- Onepot.ai — Onepot.ai offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process. It generates around fifty distinct compounds in a single workflow, eliminating the need for bespoke methods for each target. The platform employs modular couplings, deprotection, and streamlined purification steps to rapidlyassemble structurally diverse molecules. It supports chemistries that produce both sp²- and sp³-rich frameworks, enabling applications across pharmaceutical, materials, and probe development. By leveraging a catch-and-release purification protocol and iterative building-block assembly, Onepot.ai enables efficient production of complex small-molecule libraries.
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more
Investment focus
- Health Care, Software, Medical
- Seed, Series A, Series B
- United States, China, Colombia
Portfolio highlights
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Memora Health — Meet patients where they are. Digitize your clinical workflows to modernize and simplify patient care.
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Katie Haun is the CEO and Founder at Haun Ventures. She was a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School.Previously, she spent a decade as a federal prosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.
Show more
Investment focus
- Blockchain, Financial Services, FinTech
- Funding Round, Seed, Series A
- United States, United Kingdom
Portfolio highlights
- dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
- Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
- Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more
Investment focus
- E-Commerce, Robotics, Software
- Series A, Seed, Series D
- United States
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more
Investment focus
- Life Science, Biotechnology, Pharmaceutical
- Seed
- United States
Portfolio highlights
- VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
- Spring Discovery — Giving Scientists AI Superpowers
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Spain
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different.
Jay Zaveri has been serving Natural Capital as a partner since Jan 2019. He also ran venture and incubations for Social Capital, was founder of CloudOn and Future Thought Productions.
Show more
Investment focus
- Health Care, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- United States, Japan, Canada
Portfolio highlights
- Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
- BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
- Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more
Investment focus
- Artificial Intelligence, Software, Information Technology
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Singapore
Portfolio highlights
- BenchFlow — Largest benchmark hub
- Harmonyze — Harmonyze transforms fragmented franchise operations data into clear, daily, revenue-boosting recommendations with AI-powered coaching.
- Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more
Investment focus
- Biotechnology, Genetics, Life Science
- Series A, Funding Round
- United States
Portfolio highlights
- Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
- Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
- 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Peter Harris
Show more
Investment focus
- Life Science, Biotechnology, Health Diagnostics
- Seed
- United States
Portfolio highlights
- CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
Joshua Elkington
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Seed
- United States
Portfolio highlights
- Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more
Investment focus
- Software, SaaS, Enterprise Software
- Seed, Series A, Pre-Seed
- United States, Canada, Israel
Portfolio highlights
- Mason America, Inc. — Mason is the device innovation platform for product leaders who dare to deliver the next innovation in their field.
- Token Security — Token is the new approach designed for the identity boom era. Introducing Machine-First Identity Security.
- Fleet Device Management — Open-source IT and security for teams with lots of workstations and servers. (Linux, macOS, Windows, cloud, data center, OT/ICS, Chrome)
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more
Investment focus
- Health Care, Medical, Hospital
- Seed, Pre-Seed
- United States
Portfolio highlights
- Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more
Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Pre-Seed, Series A
- United States, India, Singapore
Portfolio highlights
- Blitz Electric Mobility — Blitz provides electric vehicles and fleet management software to food and beverage delivery, courier, and logistics companies.
- Paradigm — The AI-powered way to do spreadsheet work. Set up, edit, populate, and analyze sheets with assistant. Enrich empty cells with data from trusted sources.
- Inversion — Inversion is a technology-first investment company that acquires and transforms legacy businesses with blockchain technology.
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more
Investment focus
- Biotechnology, Genetics, Life Science
- Seed, Series A, Series B
- United States
Portfolio highlights
- Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more
Investment focus
- Life Science, Chemical, Genetics
- Seed, Series B, Series C
- United States
Portfolio highlights
- Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
- Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Series B
- United States, Denmark, United Kingdom
Portfolio highlights
- Tajir — Tajir offers full transparency on the prices of various products, addressing a challenge that store owners confront offline each day, and sells and delivers inventories to the stores, said the Khan brothers, whose father ran an FMCG retail distribution business for three decades.
- StudySmarter — StudySmarter is an EdTech company that develops an intelligent and content-agnostic platform for lifelong learning. It was first published in 2018 and is used by millions of learners worldwide. StudySmarter has been voted the best EdTech start-up in Germany and Europe by university representatives and education experts.
- Empirical — Culinary & scientific innovations applied in flavor to spirits and cans. From premium spirits to ready to drink cans, Empirical has an exciting selection. Order today!
Patrick Collison is a CEO of Stripe.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Series A, Seed, Series C
- United States, United Kingdom, India
Portfolio highlights
- NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
- Antithesis — At Antithesis, we want to bring the confidence and productivity benefits of autonomous testing to your team. We have developed a platform that searches for bugs in your software, in a controlled environment where all bugs are reproducible. Our first offering finds fault tolerance bugs: failures of your software that occur under specific network, hardware or timing conditions.
- Flow Engineering — Requirements management, made collaborative
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more
Investment focus
- Software, Blockchain, Internet
- Seed, Series A, Funding Round
- United States, Canada, Mexico
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series B, Series A
- United States, Spain, Germany
Portfolio highlights
- Axios Media — Smart, efficient news worthy of your time, attention, and trust. Covering local news, politics, health, climate, tech, media, business, sports, world, science and more.
- Dance — Dance is an electric mobility subscription company that makes it easy to explore your city with an electric bike or moped.
- Varo Bank — Get access to personal banking services including no monthly fee checking, high-yield savings, cash advances up to $250 and more with Varo Bank.
Alec Nielsen is the Founder & CEO at Asimov.
Show more
Investment focus
- Biotechnology, Robotics, Biopharma
- Seed
- United States
Portfolio highlights
- LatchBio — The command center for all gene-editing bioinformatics. Analyze your CRISPR data without code in 5 minutes.
- Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
- Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more
Investment focus
- Software, SaaS, Mobile
- Seed, Series A, Funding Round
- United States, Israel
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
- Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Aaron Levie is Chief Executive Officer, Cofounder and Chairman at Box, which he launched in 2005 with CFO and cofounder Dylan Smith. He is the visionary behind the Box product and platform strategy, incorporating the best of secure content collaboration with an intuitive user experience suited to the way people work today. Aaron leads the companyin its mission to transform the way people and businesses work so they can achieve their greatest ambitions. He has served on the Board of Directors since April 2005.Aaron attended the University of Southern California from 2003 to 2005 before leaving to found Box.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Series B
- United States, Czech Republic
Portfolio highlights
- Pika — The idea-to-video platform that sets your creativity in motion.
- Retell AI — RetellAI is an API for creating human-like conversational voice AI. Developers can build a voice AI similar to JARVIS in just a day — with an ~800ms response time and the ability to handle interruptions.
- Better Stack — Delightful observability tools that turn your logs & monitoring into a secret weapon for shipping better software faster.
Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
Show more
Investment focus
- Biotechnology, Cannabis, Biopharma
- Seed
- United States, Canada
Portfolio highlights
- Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
- BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
- Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, United Kingdom
Portfolio highlights
- Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Daniel M. Bradbury is Director at Liquid Grids.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Seed, Series A
- United States
Portfolio highlights
- Alume Biosciences — Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertentinjury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.
- Amplo Biotechnology — Amplo Biotechnology is a gene therapy company focused on the neuromuscular junction
Paul B. Manning has served as the chairman of our board of directors since December 2017 and as a member of our board of directors since December 2015. Mr. Manning is the Chairman and Chief Executive Officer of PBM Capital Group, LLC, a private equity investment firm in the business of investing in healthcare and life-science related companies,which he founded in 2010. Prior to that, Mr. Manning founded PBM Products in 1997, a producer of infant formula and baby food, which was sold to Perrigo Corporation in 2010. Mr. Manning is a director of Dova Pharmaceuticals, Inc., a publicly traded pharmaceutical company, as well as various private companies. Mr. Manning was previously on the board of directors of Perrigo Corporation, Concordia Healthcare Corp. and AveXis, Inc. Mr. Manning received a B.S. in microbiology from the University of Massachusetts.
Show more
Investment focus
- Biotechnology, Therapeutics, Medical
- Series A, Series B, Post-IPO Equity
- United States
Portfolio highlights
- Kriya Therapeutics — Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate humantissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
- Liquidia Technologies — Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed toimprove the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
- The Paul and Diane Manning Institute of Biotechnology — The Paul and Diane Manning Institute of Biotechnology engages in the medical research that leads to new medical treatments, including cellular therapy, gene therapy, nanotechnology and drug delivery.
Matt Vining is the current Chief Executive Officer, Board Member of Navigator CO2 Ventures. He previously worked at Navigator Energy Services as a Co-Founder and Chief Commercial Officer. Matt Vining attended Eller College of Management.
Show more
Investment focus
- Life Science, Biotechnology
- Pre-Seed
- United States
Portfolio highlights
- Bluestem Biosciences — Bluestem Biosciences, Inc., is designing biology with the end in mind to enable the existing infrastructure in the Midwest for industrialized synthetic biology.
Bill is the Chairman and Co-Founder of the Pear Tree Funds, the President of Pear Tree Investment Advisors, Inc., and the Chairman of U.S. Boston Capital Corporation. He has over 40 years of experience in the finance and investment management business.Bill holds the Chartered Financial Analyst (CFA) designation and is a member of the CFAInstitute and the Boston Security Analysts Society. He obtained his JD from Harvard Law School, an LLM in taxation from Boston University School of Law, a Masters in Personnel Administration from George Washington University, and a BS with distinction from the United States Naval Academy in Annapolis, Maryland.
Show more
Investment focus
- Analytics, Life Science, Biotechnology
- Seed
- United States
Portfolio highlights
- Thrive Bioscience — Thrive Bioscience enables quantitative biology with advanced live-cell imaging solutions, empowering researchers with data-rich, automated workflows.
Norman Sorensen who is a Class II director, joined the Board of Directors in March 2015. He is a member of the Company’s Finance, Risk Management and Audit Committee. Mr. Sorensen formerly served as chairman of the International Insurance Society, Inc., a professional organization for the insurance industry, from January 2010 until June 2013. Mr.Sorensen has served as a director of the International Insurance Society, Inc. since January 2005. Previously, from November 2011 until December 2012, he was chairman of the International Advisory Council of Principal Financial Group, Inc., a global financial investment management company. He was chairman of Principal International, Inc., serving from June 2011 to October 2012, and president and CEO of International Asset Management and Accumulation of Principal International, Inc., serving from January 2001 to June 2011. Mr. Sorensen has served as a director of Encore Capital Group, Inc., a consumer banking company, since November 2011. Mr. Sorensen also served as a director of Sara Lee Corporation, an American consumer-goods company, from January 2007 to November 2011. He has served as executive vice president of both Principal Financial Group Inc. and Principal Life Insurance Company, a life insurance company, since January 2007, and held a number of other senior management positions since 1998. Mr. Sorensen also served as chairman of the U.S. Coalition of Service Industries, a leading forum for the services sector, from January 2003 to March 2005. Mr. Sorensen served as a senior executive of American International Group, Inc., an insurance services company, from September 1989 to December 1998. He also formerly served as chairman and director of DE Master Blenders, from December 2011 until September 2013.
Show more
Investment focus
- SaaS, FinTech, Analytics
- Seed
- United States
Portfolio highlights
- Solidus Labs — The first automated, comprehensive and testable market surveillance and risk monitoring hub tailored for digital assets
- Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Leonardo DiCaprio is an American actor and film producer. He has been nominated for three Academy Awards and nine Golden Globe Awards. He won the Golden Globe Award for Best Actor for his performance in The Aviator (2004), and has been nominated by the Screen Actors Guild, Satellite Awards, and the British Academy of Film and Television Arts. Acommitted environmentalist, DiCaprio has received praise from environmental groups for his activism. At the 2007 Oscar ceremony, DiCaprio and former Vice President Al Gore announced that the Academy Awards had incorporated environmentally intelligent practices throughout the planning and production processes, and on July 7, 2007, DiCaprio presented at the American leg of Live Earth.
Show more
Investment focus
- Food and Beverage, Food Processing, Manufacturing
- Series A, Funding Round, Seed
- United States, Israel, Switzerland
Portfolio highlights
- Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
- ID Genève — We make watches that reflect the values and principles of people who are committed to fight climate change and who wish to have a positive social and environmental impact. The materials used are circular and have a lower carbon footprint than the industry average.
- SolarMente — SolarMente is a software platform that provides solar hardware, installation, warranties, financing, insurance, and technical support. The company was founded in 2020 and is headquartered in Barcelona, Catalonia.
Scott Garber is the Managing Partner of Early Light Ventures. He attended The George Washington University School of Business.
Show more
Investment focus
- Software, Information Technology, Cyber Security
- Seed, Pre-Seed, Series A
- United States
Portfolio highlights
- Ethix360 — ETHIX360 provides Compliance as a Service (CaaS); a simple, affordable answer to employee ethics communication and human resources case management.
- Ash & Erie — Men's clothes designed from scratch for shorter men 5'8" and under. Find men's casual and formal clothing from button-downs, t-shirts, sweaters, denim jeans, chinos, and more. FREE Shipping, Exchanges, and Returns.
- Outlogic — Outlogic is a provider of location data for the retail, real estate, and financial markets. Outlogic has exemplified high standards and best practices for the collection and use of location data while still allowing companies to develop disruptive tools built on a foundation of quality data.
Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
Show more
Investment focus
- Biotechnology, Genetics, Life Science
- Seed, Angel
- Canada, United States
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
A pioneer of the venture capital industry in Canada, Haig co-founded Ventures West in 1968 and spent twenty-five years working to establish the venture capital industry in Canada. Since retiring from the firm he founded, Haig has become one of the most active and successful technology angel investors on theWest Coast. He has been instrumentalin the creation, growth, and success of dozens of technology companies and careers spanning four decades. Haig has served as co-founder, chair, and director of many high-profile companies, university and industry associations, and has been honoured by the Science Council of BC and the BC Technology Industries Association with awards for lifetime achievement and contribution to technology on Canada’s West Coast.
Show more
Investment focus
- Life Science, Biotechnology, Bioinformatics
- Pre-Seed
- United States
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Dylan Taylor is a global business leader, commercial astronaut, thought leader and philanthropist. Currently, Dylan serves as Chairman & CEO of Voyager Space, a multi-national space exploration firm focused on building the next generation of space infrastructure for NASA and other global space agencies.Dylan has been recognized by HarvardUniversity, SpaceNews, the BBC, the Financial Times, Pitchbook, CNBC, CNN and others as having played a seminal role in the growth of the private space industry. As an early-stage investor in more than 50 emerging space ventures, including Axiom, Kepler, York, Astrobotic, LeoLabs, Relativity, and Planet, Dylan is widely considered the most active private space investor in the world.Dylan’s technical background, global business experience and unbridled passion for space make him a unique figure within his industry. As a thought leader and futurist, he has written many popular pieces on the future of the space industry for Forbes, FastCompany, Newsweek, SpaceNews, The Space Review, and Space.com. As a speaker, Dylan has keynoted many of the major space conferences around the world and has appeared regularly on Bloomberg, Fox Business, and CNBC.Dylan has extensive global business experience as both a board director and CEO in several industries, including advanced electronics, finance and real estate. He previously served as a Director for UMB Bank, a Fortune 500 company based in Kansas City and as a mutual fund director for the Jackson Funds where he oversaw assets of $8B across 130 distinct funds. He has also served in the roles of CEO, President and Board Director for multinational companies like Prudential PLC, Honeywell, Colliers and Jones Lang LaSalle. Dylan was recognized as a Fortune 1000 CEO with P&L responsibility in excess of $3B and operations encompassing 15,000 employees in over 60 countries. In addition, Dylan has participated in 4 IPOs over the course of his career. Dylan is a leading advocate of space manufacturing and the utilization of in-space resources to further space exploration and settlement. In 2017, he became the first private citizen to manufacture an item in space when the gravity meter he co-designed and commissioned was 3D printed on the International Space Station. The historic item is now housed in the Museum of Science and Industry in Chicago.Dylan is an explorer of note. On December 11th, 2021 Dylan became just the 606th human to go to space as part of the crew of Blue Origin’s NewShepard Mission 19. Accordingly, Dylan earned his commercial astronaut wings with the FAA and his universal astronaut wings from the Association of Space Explorers.He is also one of only a handful of humans to have descended to the deepest part of the world’s oceans, Challenger Deep in the Mariana Trench as part of the Limiting Factor Expedition in July of 2022. In that mission, Dylan descended with pilot Victor Vescovo to a depth in excess of 10,800 meters (35,500 feet) into an area of the Mariana Trench that had never been visited by humans. Dylan is the youngest human to have been to the deepest part of the world’s oceans and crossed the Karman line into Space. Dylan has been a member of the Explorers Club since 2014.Dylan maintains an extensive philanthropic impact on the space industry. In 2017, Dylan founded the nonprofit and social movement, Space for Humanity, which seeks to democratize space exploration and develop solutions to global issues through the scope of human awareness to help solve the world’s most intractable problems. Space for Humanity has successfully sent two citizen astronauts to space via Blue Origin including both the first Mexican-born woman (Katya Echazareta), and first African-born woman (Sara Sabry). Building upon his passion and support for the space industry, Dylan serves as a strategic advisor for both the Archmission and the Human Spaceflight Program and is a co-founding patron of the Commercial Spaceflight Federation, which promotes the growth of commercial space activity. Additionally, he is also a leading benefactor to the Brooke Owens Fellowship, Patti Grace Smith Fellowship and Mission: Astro Access.Dylan is the founder and Chairman of Multiverse Media, an integrated global media company focused on science and technology, with an emphasis on space. Multiverse is the parent company of the popular space philosophy website 2211.world as well as the Ad Astra Dinners, a Jeffersonian-style dinner series featuring some of the world’s leading influencers discussing the future of humanity in space. Another subsidiary of Multiverse Media, Multiverse Publishing, publishes books by leading authors including Frank White, Isaac Asimov and Gerard K. O’Neill. Multiverse is also the executive producer of the documentary film, The High Frontier and the forthcoming film, Fortitude. For his influence as a global leader and his commitment to creating a positive impact on the world, Dylan has been honored with numerous personal and professional accolades in recent years. The World Economic Forum recognized Dylan as a Young Global Leader in 2011 and a full member of the World Economic Forum in 2014. That same year he was named a Henry Crown Fellow of the Aspen Institute. In 2020, Dylan was recognized by the Commercial Spaceflight Federation with their top honor for business and finance, following in the footsteps of 2019’s inaugural winner, the late Paul Allen
and subsequent winners Jeff Bezos and Elon Musk.Dylan Taylor earned an MBA in Finance and Strategy from the Booth School of Business at University of Chicago and holds a BS in Engineering from the honors college at the University of Arizona, where he graduated Tau Beta Pi and in 2018 was named Alumnus of the year. He is also a graduate of the Global Leadership and Public Policy for the 21st Century program at Harvard University.Dylan and his family reside in Denver, Colorado where he is active locally with Colorado Concern and the Colorado Spaceport. In his spare time, Dylan enjoys hiking, competing in triathlons and spending time outdoors. As a weekend warrior athlete, Dylan has more than 25 top ten finishes and 25 age group wins to his credit, and he regularly interviews world class athletes whom have shown extraordinary resilience as the host of the Legendary Podcast. He is married to legal expert, consultant and author Gabrielle V. Taylor with whom he has two teenage daughters.
Show more
Investment focus
- Aerospace, Space Travel, Satellite Communication
- Seed, Series A, Funding Round
- United States, Canada, Finland
Portfolio highlights
- Xplore — Xplore is flying commercial missions in Earth orbits with their XCRAFT™, and they invite you to join us. They take civilian, commercial and national security payloads to their desired orbit around Earth for their science or reconnaissance missions.
- LeoLabs — LeoLabs' network of ground-based, phased array radars produces high-resolution data on objects in LEO, supporting satellite service industries.
- Space Forge — Space Forge make super materials in space that cannot be made on earth.
Don Mattrick is Chief Executive Officer of Zynga, a social game services company headquartered in San Francisco, California. His mandate is to further the company’s mission of connecting the world through games. As an industry-leading executive in entertainment, games, and consumer products, Mattrick has firmly established himself during a 30-yearcareer as a world-class leader of game, platform, and team development.Before joining Zynga in 2013, Mattrick, 49, spent six years at Microsoft – the last three as President of the Interactive Entertainment Business. He was responsible for leading the team that grew Microsoft’s Xbox 360 global installed base by 700 percent, to nearly 75 million consoles, and Xbox Live membership from 6 million to nearly 50 million subscribers in 41 countries. During his tenure at Microsoft, Mattrick also oversaw businesses and services focused on consumer products, including PC and mobile interactive entertainment and the groundbreaking Kinect entertainment products; the Kinect was released in November 2010 and set a Guinness World Record for the fastest-selling consumer electronic device in its first 60 days. Mattrick is widely recognized for transforming the Microsoft Interactive Entertainment Business from one that was operating at a loss into a sustained and profitable business.Prior to Microsoft, Mattrick served in several leadership positions at Electronic Arts, most recently as President of Worldwide Studios, in which capacity he oversaw EA's global studios and research & development in several major sites, including Redwood Shores, Calif. (Silicon Valley), Los Angeles, EA Tiburon in Florida, EA Canada in Vancouver, British Columbia, and Montreal, and EA U.K. During his 15-year career at Electronic Arts, Mattrick helped develop and scale the company’s leading global game franchises and brands, including Need for Speed, FIFA, and The Sims.Mattrick founded his first company, Distinctive Software, at age 17; it was acquired by Electronic Arts in 1991 and subsequently became EA Canada.Over the years, Mattrick has been broadly recognized for his work in the technology industry. In 2011, he was featured in Fortune Magazine as one of the "Smartest People in Tech,” highlighting his leadership in growing the Xbox business, including the pivotal role he played in driving new consumer innovations such as Kinect; and in May 2012, he was named one of CNN Money’s top 10 “brilliant technology visionaries.”Raised in Vancouver, British Columbia, Mattrick is married with two children. In acknowledgement of his role in building the interactive entertainment business in Canada and the active development of industry links with the University of British Columbia, Mattrick received the UBC Award as an Honorary Fellow from the Sauder School of Business and was awarded the highest honor Simon Fraser University can bestow, the Doctor of Laws. He has served on several public and private boards, including the advisory board for USC School of Cinematic Arts.
Show more
Investment focus
- SaaS, Life Science, Non-Fungible Token (NFT)
- Series B, Seed, Series A
- Canada, United States
Portfolio highlights
- Dapper Labs — Dapper Labs uses the power of play to deliver blockchain-based experiences that are made for you and ready for the real world.
- Mino Games — Mino Games is a free-to-play mobile gaming studio that produced the top 50 grossing mobile game Mino Monsters, with over 13 million downloads. We create deeply engaging, widely appealing games for millions of fans. We’re currently building our world class development studio in Montreal.We are a small group of passionate engineers, artists andanalysts with a mission to create games that millions of people all around the world love to play for years. We are funded by the best angel investors, institutional investors, and gaming companies from across the world.Our third and latest game, Cat Game, has already hit the App Store’s Top 100 Grossing Chart in Canada. The game, currently in soft launch, is showing world class key metrics, and we are expecting it to be a global hit when we launch it by February 2019.We are looking today to grow the team and looking for world class ambitious talent to come join us on the journey, to develop and support this newest title into a global success on both iOS and Android, and help us with future projects as we rapidly grow.
- Epicrop Technologies — The only company using a nature-based epigenetic approach to enhance crops, accelerating development and delivering proven results.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Web3
Organic Food
Art
Big Data
Video Games
Publishing
Wellness
B2B
Food and Beverage
Android
Payments
Real Estate
Finance
Education
Digital Media
Financial Services
Retail
Manufacturing
Infrastructure
Beauty
Photography
Construction
Biotechnology
Travel
Fitness
Recruiting
Sports
Hospitality
Mobile Advertising
Platforms
Cannabis
Franchise
Automotive
Social
eSports
Wine And Spirits
Medical Device
Crowdfunding
Mobile
CleanTech
Enterprise Software
Mobile Apps
Music
Transportation
InsurTech
Email
Enterprise
Social Media
Social Network
LGBT
Medical
Legal
Local
Internet
Renewable Energy
Oil and Gas
Fashion
Film
Life Science
Theatre
Non Profit
SaaS
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Cryptocurrency
Agriculture (agtech)
Machine Learning
Media (entertainment)
Facebook
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Armenia
Ghana
Saudi Arabia
Egypt
Belarus
Hungary
Oceania
Finland
Africa
France
Croatia
LATAM
Gibraltar
Asia
Barbados
Georgia
Greece
Brazil
Czech Republic
Liechtenstein
Faroe Islands
Costa Rica
Hong Kong
Panama
Bahrain
Belgium
Myanmar
Denmark
Lithuania
Bermuda
Estonia
Algeria
Ecuador
Malaysia
Bulgaria
Belize
Chile
Peru
Ethiopia
Togo
Rwanda
Slovenia
Poland
Liberia
Uganda
Jersey
Lebanon
San Marino
Sweden
Serbia
Sierra Leone
Thailand
Norway
Tanzania
Uzbekistan
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
Mexico
El Salvador
Puerto Rico
Senegal
Italy
Zimbabwe
Tunisia
Venezuela
Ukraine
Mali
Philippines
Taiwan
Dominican Republic
Israel
Bahamas
Kuwait
Iraq
Mauritius
Iceland
Malta
Azerbaijan
Nigeria
Morocco
Namibia
Nicaragua
United Arab Emirates
Jamaica
Honduras
Luxembourg
Isle of Man
Bolivia
Pakistan
Kazakhstan
Albania
Romania
Jordan
Grenada
Argentina
Bangladesh
Kenya
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Colombia
Seychelles
Guatemala
Marshall Islands
Angel Investors in United States by industry
Transportation
Biotech
Health Care
EdTech
Climate
Impact
Marketplace
Proptech
Community
Artificial intelligence
Hardware
Enterprise
Gaming
Restaurants
Energy
Venture Capital
Sustainability
Retail
FinTech
Financial Services
LGBT
Oil and Gas
Film
Cryptocurrency
Education
Payments
Finance
Wine And Spirits
Video Games
Publishing
Wellness
Manufacturing
Social Media
Celebrity
Digital Media
Art
Social Network
Blockchain
Mobile Advertising
Legal
Construction
Google
Software
Non Profit
Local
Enterprise Software
Sports
Hospitality
eSports
InsurTech
CleanTech
Biotechnology
Platforms
Cannabis
Real Estate
Organic Food
Infrastructure
Fashion
Social
Beauty
Web3
Theatre
Life Science
Photography
Sporting Goods
Big Data
Clean Energy
Medical
Renewable Energy
Fitness
Mobile Apps
Mobile
B2B
Social Impact
Email
Internet
Recruiting
Food and Beverage
SaaS
Medical Device
Music
Crowdfunding
Android
Agriculture (agtech)
Travel
Franchise
Facebook
Machine Learning
Media (entertainment)
Consumer
Automotive